851 related articles for article (PubMed ID: 25111131)
1. Current issues of RNAi therapeutics delivery and development.
Haussecker D
J Control Release; 2014 Dec; 195():49-54. PubMed ID: 25111131
[TBL] [Abstract][Full Text] [Related]
2. Delivery of RNAi therapeutics: work in progress.
Miller AD
Expert Rev Med Devices; 2013 Nov; 10(6):781-811. PubMed ID: 24195461
[TBL] [Abstract][Full Text] [Related]
3. Development of RNAi technology for targeted therapy--a track of siRNA based agents to RNAi therapeutics.
Zhou Y; Zhang C; Liang W
J Control Release; 2014 Nov; 193():270-81. PubMed ID: 24816071
[TBL] [Abstract][Full Text] [Related]
4. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells.
Landesman-Milo D; Goldsmith M; Leviatan Ben-Arye S; Witenberg B; Brown E; Leibovitch S; Azriel S; Tabak S; Morad V; Peer D
Cancer Lett; 2013 Jul; 334(2):221-7. PubMed ID: 22935680
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of RNAi nanomedicines.
Barros SA; Gollob JA
Adv Drug Deliv Rev; 2012 Dec; 64(15):1730-7. PubMed ID: 22732527
[TBL] [Abstract][Full Text] [Related]
7. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
8. RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges.
Won Lee J; Kyu Shim M; Kim H; Jang H; Lee Y; Hwa Kim S
Adv Drug Deliv Rev; 2023 Oct; 201():115073. PubMed ID: 37657644
[TBL] [Abstract][Full Text] [Related]
9. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
10. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
11. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics.
Martirosyan A; Olesen MJ; Howard KA
Adv Genet; 2014; 88():325-52. PubMed ID: 25409611
[TBL] [Abstract][Full Text] [Related]
13. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
DeVincenzo JP
Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li SD; Huang L
Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
[TBL] [Abstract][Full Text] [Related]
16. Delivery vehicles for small interfering RNA in vivo.
de Fougerolles AR
Hum Gene Ther; 2008 Feb; 19(2):125-32. PubMed ID: 18257677
[TBL] [Abstract][Full Text] [Related]
17. Optimization of siRNA delivery to target sites: issues and future directions.
Khalil IA; Yamada Y; Harashima H
Expert Opin Drug Deliv; 2018 Nov; 15(11):1053-1065. PubMed ID: 30198792
[TBL] [Abstract][Full Text] [Related]
18. RNA interference for therapy in the vascular endothelium.
Kaufmann J; Ahrens K; Santel A
Microvasc Res; 2010 Sep; 80(2):286-93. PubMed ID: 20144624
[TBL] [Abstract][Full Text] [Related]
19. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
Andersen MØ; Howard KA; Kjems J
Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge.
Huang X; Chau Y
Mol Pharm; 2021 Jan; 18(1):377-385. PubMed ID: 33295773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]